Showing results (201-210 of 221) with videos related to

Sort By:
Pageof 23
Journal of Affective Disorders|December 29, 2004
Communicative skills of general practitioners augment the effectiveness of guideline-based depression treatmentTitus W D P van Os, Rob H S van den Brink, Bea G Tiemens, et al.
Journal of Affective Disorders|August 9, 2002
Effects on depression pharmacotherapy of a Dutch general practitioner training programT W D P van Os, R H S van den Brink, J A Jenner, et al.
Psychological Medicine|December 17, 2005
Short-term effects of enhanced treatment for depression in primary care: results from a randomized controlled trialA Smit, H Kluiter, H J Conradi, et al.
General Hospital Psychiatry|June 14, 2002
Predictability of the one-year course of depression and generalized anxiety in primary careRob H S van den Brink, Johan Ormel, Bea G Tiemens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancerP Schöffski, B Thate, G Beutel, et al.
Evolution & Development|November 1, 2006
Mitogenomics and phylogenomics reveal priapulid worms as extant models of the ancestral EcdysozoanBonnie L Webster, Richard R Copley, Ronald A Jenner, et al.
FEBS Letters|October 24, 1994
Intense oxidative DNA damage promoted by L-dopa and its metabolites. Implications for neurodegenerative diseaseJ P Spencer, A Jenner, O I Aruoma, et al.
BMC Evolutionary Biology|March 6, 2017
Comparative analyses of glycerotoxin expression unveil a novel structural organization of the bloodworm venom systemSandy Richter, Conrad Helm, Frederic A Meunier, et al.
Psychological Medicine|September 3, 1999
Training primary-care physicians to recognize, diagnose and manage depression: does it improve patient outcomes?B G Tiemens, J Ormel, J A Jenner, et al.
Investigational New Drugs|May 5, 2012
Eribulin mesylate pharmacokinetics in patients with solid tumors receiving repeated oral ketoconazoleL A Devriese, M Mergui-Roelvink, J Wanders, et al.
Pageof 23